A Phase2 of A-101 Topical Solution in Subjects With Common Warts
Public ClinicalTrials.gov record NCT03210337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Study identification
- NCT ID
- NCT03210337
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aclaris Therapeutics, Inc.
- Industry
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Interventions
- A-101 Topical Solution Drug
- A-101 Vehicle Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 8 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2017
- Primary completion
- Mar 15, 2018
- Completion
- Mar 15, 2018
- Last update posted
- Apr 30, 2019
2017 – 2018
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigational Site | Scottsdale | Arizona | 85225 | — |
| Aclaris Investigational Site | Rogers | Arkansas | 72758 | — |
| Aclaris Investigational Site | San Diego | California | 92103 | — |
| Aclaris Investigational Site | San Diego | California | 92123 | — |
| Aclaris Investigational Site | Miami | Florida | 33137 | — |
| Aclaris Investigational Site | Newnan | Georgia | 30263 | — |
| Aclaris Investigational Site | Arlington Heights | Illinois | 60005 | — |
| Aclaris Investigational Site | Indianapolis | Indiana | 46256 | — |
| Aclaris Investigational Site | Plainfield | Indiana | 46168 | — |
| Aclaris Investigational Site | Warren | Michigan | 48088 | — |
| Aclaris Investigational Site | Fridley | Minnesota | 55432 | — |
| Aclaris Investigational Site | New York | New York | 10155 | — |
| Aclaris Investigational Site | Broomall | Pennsylvania | 19008 | — |
| Aclaris Investigational Site | Fort Washington | Pennsylvania | 19034 | — |
| Aclaris Investigational Site | Fountain Inn | South Carolina | 29644 | — |
| Aclaris Investigational Site | Austin | Texas | 78759 | — |
| Aclaris Investigational Site | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03210337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03210337 live on ClinicalTrials.gov.